PORTLAND, Oregon, May 20, 2026
Araceli Biosciences announced the launch of Endeavor® Live Cell, a new ultra-high-throughput kinetic imaging platform designed to support the growing demands of AI-driven drug discovery and advanced Lab-in-the-Loop experimental workflows. The new system expands Araceli’s existing imaging platform into dynamic live-cell biology, enabling researchers to generate large-scale cellular imaging datasets with the speed, consistency, and automation compatibility required for modern pharmaceutical screening environments. The company stated that Endeavor® Live Cell is capable of capturing approximately four-minute imaging timepoints across entire 1536-well plates, allowing scientists to monitor cellular behavior in real time during large-scale screening campaigns.
Araceli Biosciences said the launch reflects a broader shift occurring across the drug discovery industry as artificial intelligence platforms increasingly depend on high-quality biological data rather than traditional endpoint measurements alone. Modern AI-enabled drug discovery systems require continuous experimental feedback loops where imaging, analysis, prediction, and experimental validation operate together in highly automated environments. According to the company, conventional imaging platforms often struggle to provide the speed and scalability necessary to support these workflows, particularly for live-cell kinetic biology experiments involving thousands of simultaneous samples. Endeavor® Live Cell was specifically developed to address this infrastructure gap while helping researchers generate reproducible cellular datasets optimized for machine learning and advanced computational biology applications.
Endeavor® Live Cell Expands High-Throughput Kinetic Biology Capabilities
Araceli Biosciences explained that the platform enables live-cell imaging at screening scale while maintaining full-plate consistency, environmental stability, and automation compatibility. The company noted that many biological processes critical to drug discovery occur dynamically over time rather than as static endpoint events, making rapid kinetic imaging increasingly important for understanding complex cellular responses. Endeavor® Live Cell allows researchers to observe cellular activity as it unfolds, supporting experiments where timing and repeated measurements are essential to identifying meaningful biological signals.
The system supports a wide range of applications across pharmaceutical and biotechnology research, including compound response analysis, cell health and viability monitoring, phenotypic screening, organoid and spheroid growth tracking, and kinetic assay development. These applications are becoming increasingly important in areas such as oncology, neuroscience, immunology, regenerative medicine, and precision therapeutics, where subtle temporal changes in cell behavior may influence therapeutic outcomes. By enabling rapid imaging cycles across full 1536-well plates, the platform allows researchers to scale live-cell experiments into ultra-high-throughput environments that were previously difficult to achieve using traditional microscopy systems.
Matt Beaudet, President and Chief Executive Officer of Araceli Biosciences, stated that the company’s objective is not simply to increase imaging speed but to help scientists generate the high-quality biological datasets required for next-generation drug discovery. He emphasized that dynamic biology introduces additional operational challenges where imaging consistency, timing precision, and automation integration become critical for reliable experimental performance.
Advertisement
Partnership with Okolab Strengthens Environmental Control Infrastructure
The Endeavor® Live Cell platform was developed through a strategic collaboration with Okolab, a company specializing in environmental control systems for live-cell microscopy applications. Okolab contributed expertise in stable incubation systems and environmental regulation technologies designed to maintain optimal live-cell experimental conditions during extended imaging workflows. Araceli stated that combining Okolab’s environmental control capabilities with its own ultra-high-throughput imaging technology creates a platform capable of maintaining both biological stability and operational scalability during large screening campaigns.
According to the companies, maintaining precise environmental conditions during live-cell imaging experiments is essential for generating reproducible biological data. Variations in temperature, humidity, carbon dioxide levels, or incubation stability can significantly affect cell behavior and compromise experimental accuracy. By integrating environmental control directly into the high-throughput imaging workflow, Endeavor® Live Cell aims to reduce variability while supporting longer-term kinetic biology experiments in highly automated laboratory settings.
Lara Petrak, Director of Sales for Okolab USA, stated that the collaboration enables scientists to study dynamic biology across large-scale screening workflows without sacrificing environmental stability or imaging consistency. She noted that combining environmental precision with high-speed imaging and automation readiness creates new opportunities for researchers conducting complex live-cell studies at pharmaceutical scale.
AI-Driven Drug Discovery Increases Demand for Advanced Imaging Platforms
The launch of Endeavor® Live Cell comes as pharmaceutical companies increasingly invest in AI-enabled drug discovery platforms, automated laboratories, and computational biology infrastructure capable of accelerating therapeutic development timelines. Industry experts believe that future AI-driven research systems will rely heavily on continuous experimental feedback loops where biological imaging data is rapidly generated, analyzed by machine learning systems, and used to guide subsequent experimental decisions in near real time.
Araceli Biosciences stated that the company intends to position itself as a critical imaging infrastructure provider supporting these next-generation research environments. As Lab-in-the-Loop experimentation becomes more widely adopted across pharmaceutical and biotechnology industries, scalable live-cell imaging systems capable of generating consistent high-dimensional biological data are expected to become increasingly important for both therapeutic discovery and translational research programs.
Source: Araceli Biosciences press release
